Voxilaprevir chemical

Get a Price/Quote

Voxilaprevir chemical Specification

Molecular Formula
C40H52F4N6O9S

Storage
Freezer

Molecular Weight
868.93 Kilograms (kg)

Place of Origin
China

Other Names
GS9857;Voxilaprevir

CAS No
1535212-07-7

Grade
Medicine Grade

Usage
Voxilaprevir is a hepatitis C virus (HCV) nonstructural (NS) protein 3/4A protease inhibitor that is used in combination with sofosbuvir and velpatasvir.

Purity
99%

Appearance
powdr

Smell
Other

Color
Other

Form
Powder

Voxilaprevir chemical Trade Information

Minimum Order Quantity
1 Ton

FOB Port
Shanghai

Payment Terms
Letter of Credit (L/C), Letter of Credit at Sight (Sight L/C), Delivery Point (DP), Cash Against Delivery (CAD), Telegraphic Transfer (T/T), Days after Acceptance (DA)

Supply Ability
1000 Tons Per Week

Delivery Time
10 Days

Sample Available
Yes

Sample Policy
Contact us for information regarding our sample policy

Main Export Market(s)
Australia, Eastern Europe, Western Europe, Middle East, Africa, Central America, South America, Asia, North America

About Voxilaprevir chemical

1R2RN1R2R255difluoro53hydroxy6methoxy2quinoxalinylpentylcyclopropyloxycarbonyl3methylLvalyl3S4R3Ethyl4hydroxyLprolyl1amino2difluoromethylN1 methylcyclopropylsulfonylcyclopropanecarboxamide cyclic 1 2ether

CAS NO 1535212077

Molecular Formula C40H52F4N6O9S

Molecular Weight 86893

Potent Hepatitis C Virus Treatment

Voxilaprevir acts by inhibiting the NS3/4A protease, a crucial protein for hepatitis C virus replication. When used alongside sofosbuvir and velpatasvir, it enhances the therapeutic regimen against HCV, offering a robust option for patients seeking effective viral clearance. Its high purity and specialized storage requirements ensure consistent performance in clinical settings.

Pharmaceutical Grade and Quality Assurance

Manufactured under strict standards in China, Voxilaprevir is supplied with a purity of 99%. This guarantees reliable integration into medical formulations. As a medicine grade product, it meets the highest industry benchmarks for safety, efficacy and quality, ensuring optimal results for end users and healthcare professionals.

FAQs of Voxilaprevir chemical:

Q: How should Voxilaprevir be stored to maintain its efficacy?

A: Voxilaprevir should be stored in a freezer to ensure its stability and preserve its potency. Maintaining the appropriate storage conditions helps retain its effectiveness in pharmaceutical applications.

Q: What is the primary usage of Voxilaprevir in medicine?

A: Voxilaprevir is primarily used as a hepatitis C virus (HCV) NS3/4A protease inhibitor. It forms part of a combination therapy with sofosbuvir and velpatasvir for treating chronic HCV infections.

Q: When is Voxilaprevir typically administered in the clinical setting?

A: Voxilaprevir is administered as part of a prescribed antiviral regimen for patients diagnosed with hepatitis C. Timing and dosage depend on medical guidelines and patient-specific factors assessed by healthcare professionals.

Q: Where is Voxilaprevir manufactured and supplied from?

A: Voxilaprevir is manufactured and supplied from China, where pharmaceutical companies specialize in the production, export, and distribution of high-grade chemical ingredients.

Q: What is the process of using Voxilaprevir in combination therapy?

A: In clinical practice, Voxilaprevir is combined with sofosbuvir and velpatasvir to enhance treatment efficacy against HCV. This multi-drug approach is designed to target multiple viral proteins and increase the likelihood of successful outcomes.

Q: What are the benefits of using Voxilaprevir in HCV treatment protocols?

A: Using Voxilaprevir provides potent inhibition of a key viral protein, improving viral clearance and treatment success rates when used in combination therapies. Its high purity ensures consistent results and patient safety.

Tell us about your requirement